Skye Bioscience (SKYE) Non-Current Assets (2012 - 2026)
Skye Bioscience (SKYE) posted Non-Current Assets of $74,908 for Q2 2026, down 95.3% from $1.58 million a year earlier and down 91.2% from the prior quarter.
Skye Bioscience (SKYE) Non-Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience's Non-Current Assets came in at $1.22 million, down 37.0% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of 178.0% (FY2020 to FY2025).
- In prior years, Skye Bioscience's Non-Current Assets was $1.94 million in FY2024 (+568.8%), $289,568 in FY2023 (+73.0%), $167,354 in FY2022 (-31.1%) and $242,991 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q2 2021.
- On a year-over-year basis, Non-Current Assets has declined in each of the last four quarters, with growth averaging 236.0% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2022, with growth of 889.3%; the weakest was Q2 2026, with a decline of 95.3%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $849,767 (Q1 2026), $1.22 million (Q4 2025) and $1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 74,908.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74,908.00 |
| Mar 31, 2026 | 849,767.00 |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 1.94 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 257,068.00 |
| Mar 31, 2024 | 265,189.00 |
| Dec 31, 2023 | 289,568.00 |
| Sep 30, 2023 | 318,141.00 |
| Jun 30, 2023 | 343,257.00 |
| Mar 31, 2023 | 136,040.00 |
| Dec 31, 2022 | 167,354.00 |
| Sep 30, 2022 | 185,536.00 |
| Jun 30, 2022 | 193,542.00 |
| Mar 31, 2022 | 218,012.00 |
| Dec 31, 2021 | 242,991.00 |
| Sep 30, 2021 | 253,279.00 |
Skye Bioscience Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();